| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 5,357 | 8,096 | 6,507 | 7,194 | | Selling General and Administrative | 1,728 | 1,316 | 1,348 | 1,313 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,086) | (9,411) | (7,855) | (8,507) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 32 | 4,169 | 453 | (501) | | Earnings Before Interest And Taxes | (7,053) | (5,243) | (7,402) | (9,008) | | Interest Expense | 41 | 41 | 27 | 5 | | Income Before Tax | (7,094) | (5,283) | (7,428) | (9,013) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,094) | (5,283) | (7,428) | (9,013) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,094) | (5,283) | (7,428) | (9,013) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,094) | ($5,283) | ($7,428) | ($9,013) |
|
0.49% Nasdaq 
Income Statement
